Skip to content

Where Are We Now With PrEP

Click to view larger version.

The Pathway to Access and Impact

This graphic outlines the critical steps for rolling out long-acting injectable PrEP products.

The Pathway to Access and Impact graphic


Long-Acting PrEP: Priority Slides

Click for downloadable version.


Comparing Product Approvals, Volume, Implementation, and Price: Update October 2025

LEN Regulatory Approval

map of LEN approvals in Africa

Click to view larger version.

LEN Implementation Studies

map of LEN implementation studies

Click to view larger version.

CAB Regulatory Approval

map of CAB regulatory approvals around the world

Click to view larger version.

CAB Volume

charts discussing CAB volumes to low and middle income countries

Click to view larger version.

CAB Implementation

world map of CAB ongoing and planned implementation studies

Click to view larger version.

DVR Regulatory Approval

map of DVR approvals in Africa

Click to view larger version.

DVR Volume

chart of the allocation of DVR to low and middle income countries

Click to view larger version.

DVR Implementation

map of ongoing and planned implementation studies

Click to view larger version.

PrEP Price Comparison

View larger version.

Moving a Product to the Real World

View larger version.

Potential Market of LEN for PrEP

View larger version.

LEN Generics — Can we go faster?

View larger version.

An Overview of Lenacapavir for PrEP Trials

View larger version.

Tracking Lenacapavir Rollout

View larger version.